ESR1 and breast carcinoma: Triple negative breast cancer (TNBC), which is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, accounts for 10–17% of all breast carcinomas[11–20].